Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis
Treatment of oral squamous cell carcinoma (OSCC) is based on clinical exam, biopsy, and a precise imaging-based TNM-evaluation. A high sensitivity and specificity for magnetic resonance imaging (MRI) and F-18 FDG PET/CT are reported for N-staging. Nevertheless, staging of oral squamous cell carcinom...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
24 May 2022
|
| In: |
European journal of nuclear medicine and molecular imaging
Year: 2022, Volume: 49, Issue: 11, Pages: 3870-3877 |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-022-05843-4 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00259-022-05843-4 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00259-022-05843-4 |
| Author Notes: | Egon Burian, Benjamin Palla, Nicholas Callahan, Thomas Pyka, Constantin Wolff, Claudio E. von Schacky, Annabelle Schmid, Matthias F. Froelich, Johannes Rübenthaler, Marcus R. Makowski, Felix G. Gassert |
| Summary: | Treatment of oral squamous cell carcinoma (OSCC) is based on clinical exam, biopsy, and a precise imaging-based TNM-evaluation. A high sensitivity and specificity for magnetic resonance imaging (MRI) and F-18 FDG PET/CT are reported for N-staging. Nevertheless, staging of oral squamous cell carcinoma is most often based on computed tomography (CT) scans. This study aims to evaluate cost-effectiveness of MRI and PET/CT compared to standard of care imaging in initial staging of OSCC within the US Healthcare System. |
|---|---|
| Item Description: | Gesehen am 18.09.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-022-05843-4 |